Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces Pricing of Marketed Short Form Prospectus Offering of Units

Newsfile May 14, 2020

RETRANSMISSION: Innocan Pharma Announces up to $10 Million Public Offering of Units

Newsfile May 12, 2020

Innocan Pharma Announces up to $10 Million Public Offering of Units

Newsfile May 11, 2020

InnoCan Announces Appointment of Professor Daniel Offen, Scientific Advisory Director

Newsfile May 1, 2020

InnoCan to Develop a New Lines of CBD Products for Tamar Technologies

Newsfile April 28, 2020

InnoCan Pharma Collaborates with Tel Aviv University to Develop a New Revolutionary Approach to Treat the COVID-19 Corona Virus with Exosomes-Loaded CBD

Newsfile April 17, 2020

InnoCan Provides Update and Summary About Its Corporate Progress as Its First Products Prepare to Enter the Commercial Marketplace

Newsfile February 11, 2020

InnoCan Pharma Announces Patent Application for Novel Hemorrhoid Treatment

Newsfile February 5, 2020

InnoCan Signs its First Distribution Agreement with "Active Therapeutics" for InnoCan's CBD Derma Cosmetics products in the United Kingdom and Ireland

Accesswire January 28, 2020

InnoCan Announces Appointment of Prominent Healthcare Executive, Peter Bloch as a Director

Accesswire January 23, 2020

InnoCan Announces Successful Research Study Advancing Its Development of Cannabidiol Targeted Injection Delivery Platform

Accesswire January 13, 2020

InnoCan Reports Q3 Financial Results and Business Update

Accesswire November 29, 2019

InnoCan Signs Agreement to Manufacture Products in the U.S.

Accesswire November 18, 2019

Canadian Securities Exchange Attracts First Israeli Company Listings

Newsfile November 5, 2019

InnoCan Pharma Signs an Agreement with Fancystage Unipessoal LDA, a Leading Cosmetics Manufacturer to produce CBD Cosmetics to the European Market

Accesswire November 5, 2019

InnoCan Pharma Plans to Enter CBD Beauty Market with Launch of InnoCan Branded Cosmetic Products in H1/20

Accesswire October 21, 2019

Canadian Securities Exchange Reports Strong Trading Activity, Listings Growth and Other Milestones in Third Quarter of 2019

Newsfile October 16, 2019